Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Apricus Biosciences Inc (NASDAQ:APRI)

1.16
Delayed Data
As of Jun 23
 +0.07 / +6.42%
Today’s Change
0.86
Today|||52-Week Range
5.95
-10.77%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Revenue and IncomeNet Revenues464.0K4.3M356.0K0.00
 
 
 
 
Cost of Goods Sold21.0K3.4M2.0K0.00
 
 
 
 
Depreciation And Amortization72.0K72.0K72.0K56.0K
 
 
 
 
 
 
Operating ExpensesGross Income371.0K826.0K282.0K-56.0K
 
 
 
 
 
General Expenses5.1M2.2M2.8M1.8M
 
 
 
 
 
Research And Development2.8M409.0K829.0K412.0K
 
 
 
 
 
Total Operating Expenses5.2M5.7M2.8M1.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.7M-1.4M-2.5M-1.9M
 
 
 
 
 
Extraordinary Credit1.6M626.0K2.4M--
 
 
 
 
Extraordinary Charge0.000.000.00-1.4M
 
 
Interest Expense On Debt258.0K507.0K234.0K95.0K
 
 
 
 
 
Other Expenses0.00-11.0K-20.0K-26.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-3.3M-1.3M-306.0K-3.4M
 
 
 
 
 
Income Taxes-2.0K-1.0K-7.0K0.00
 
 
 
 
Discontinued Operations0.000.000.00-340.0K
 
 
Extraordinary Items0.000.000.0011.8M
 
 
Net Income-3.3M-1.3M-299.0K-3.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS6.2M6.6M7.7M7.7M
 
 
 
 
 
Shares To Calculate EPS Diluted6.2M6.6M7.7M7.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.50-$1.90-$0.04$1.04
 
 
 
 
 
EPS Diluted-$0.50-$0.19-$0.04-$0.48